Pertussis in Argentina and France

Vaccine

Volumn 25, Issue 22, 2007, Pages 4335-4339

  Caro, Valérie ^a   Bouchez, Valérie ^a   Guiso, Nicole ^a   Gatti, Blanca ^b   Agosti, Maria Rosa ^b   Ayala, Silvia E Gonzàlez ^b  

^a CNRS   (France)

^b Hospital de Ninos Sor Maria Ludovica   (Argentina)

Author keywords

Argentina; Bordetella pertussis; France; Genotyping; Pulsed field gel electrophoresis

Indexed keywords

PERTUSSIS VACCINE;

ARGENTINA; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FRANCE; GENOTYPE; HUMAN; INFANT; LETTER; MALE; MOLECULAR EVOLUTION; PERTUSSIS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SINGLE DRUG DOSE; VACCINATION;

ARGENTINA; BACTERIAL TYPING TECHNIQUES; BORDETELLA PERTUSSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; EVOLUTION, MOLECULAR; FEMALE; FRANCE; GENOTYPE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; MALE; PERTUSSIS VACCINE; VACCINATION; WHOOPING COUGH;

EID: 34247855893     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.08.024     Document Type: Letter

References (35)

1. Wirsing von Konig C.H., Halperin S., Riffelmann M., and Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2 12 (2002) 744-750
2. Tanaka M., Vitek C.R., Pascual F.B., Bisgard K.M., Tate J.E., and Murphy T.V. Trends in pertussis among infants in the United States, 1980-1999. JAMA 290 22 (2003) 2968-2975
3. Rohani P., Green C.J., Mantilla-Beniers N.B., and Grenfell B.T. Ecological interference between fatal diseases. Nature 422 6934 (2003) 885-888
4. Grimprel E., Njamkepo E., Begue P., and Guiso N. Rapid diagnosis of pertussis in young infants: comparison of culture, PCR, and infant's and mother's serology. Clin Diagn Lab Immunol 4 6 (1997) 723-726
5. Netherlands Hcot. Vaccination against pertussis. Health council of the Netherlands 2004. 2004; 2004/04: http://www.gr.nl.
6. Forsyth K., Tan T., von Konig C.H., Caro J.J., and Plotkin S. Potential strategies to reduce the burden of pertussis. Aims, scope and findings of the global pertussis initiative. Pediatr Infect Dis J 24 5 Suppl. (2005) S69-S74
7. Hallander H.O., Advani A., Donnelly D., Gustafsson L., and Carlsson R.M. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during Three Periods Marked by Different Vaccination Programs. J Clin Microbiol 43 6 (2005) 2856-2865
8. Weber C., Boursaux-Eude C., Coralie G., Caro V., and Guiso N. Polymorphism of Bordetella pertussis isolates circulating the last ten years in France, where a single effective whole-cell vaccine has been used for more than thirty years. J Clin Microbiol 39 12 (2001) 4396-4403
9. Schouls L.M., van der Ende A., van de Pol I., Schot C., Spanjaard L., Vauterin P., et al. Increase in genetic diversity of Haemophilus influenzae serotype b (Hib) strains after introduction of Hib vaccination in The Netherlands. J Clin Microbiol 43 6 (2005) 2741-2749
10. Elomaa A., Advani A., Donnelly D., Antila M., Mertsola J., Hallander H., et al. Strain Variation among Bordetella pertussis Isolates in Finland, Where the Whole-Cell Pertussis Vaccine Has Been Used for 50 Years. J Clin Microbiol 43 8 (2005) 3681-3687
11. Edwards K.M., and Decker M.D. Pertussis vaccine. In: Plotkin S., Orenstein W.A., and Offit P.A. (Eds). Vaccines. 4th ed. (2004), Saunders, Philadelphia p. 471-528
12. Godfroid F., Denoel P., and Poolman J. Are vaccination programs and isolate polymorphism linked to pertussis re-emergence?. Exp Rev Vaccines 4 5 (2005) 757-778
13. Fingermann M., Fernandez J., Sisti F., Rodriguez M.E., Gatti B., Bottero D., et al. Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production. Vaccine 24 17 (2006) 3513-3521 [Epub 2006 Feb 28]
14. Caro V., Njamkepo E., Van Amersfoorth S.C., Mooi F.R., Advani A., Hallander H.O., et al. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect 7 7-8 (2005) 976-982
15. van Amersfoorth S.C., Schouls L.M., van der Heide H.G., Advani A., Hallander H.O., Bondeson K., et al. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol 43 6 (2005) 2837-2843
16. Baron S., Njamkepo E., Grimprel E., Begue P., Desenclos J.C., Drucker J., et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J 17 5 (1998) 412-418
17. Gilberg S., Njamkepo E., Du Chatelet I.P., Partouche H., Gueirard P., Ghasarossian C., et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis 186 3 (2002) 415-418
18. Renacoq elp. http://www.invs.sante.fr/recherche/index2.asp?txtQuery=renacoq.
19. Riva Posse C.A., and Miceli I.N. Pertussis: its evolution in Argentina at the end of the twentieth century. Medicina (Buenos Aires) 65 1 (2005) 7-16
20. Anonymous. Avis du Conseil supérieur d'hygiène publique de France du 13 mars 1998. Calendrier vaccinal 1998. Bull Epidemiol Heb 15 (1998) 61-64
21. Njamkepo E., Rimlinger F., Thiberge S., and Guiso N. Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity. Vaccine 20 9-10 (2002) 1290-1294
22. Grimprel E., Baron S., Levy-Bruhl D., Garnier J.M., Njamkepo E., Guiso N., et al. Influence of vaccination coverage on pertussis transmission in France. Lancet 354 9191 (1999) 1699-1700
23. Bonmarin I., Bouraoui L., Guiso N., and Njamkepo E. Renacoq elp. Renacoq: surveillance de la coqueluche à l'hôpital en 2004. Bull Epidemiol Heb 17 (2006) 113-115
24. Dalet K., Weber C., Guillemot L., Njamkepo E., and Guiso N. Characterization of adenylate cyclase-hemolysin gene duplication in a Bordetella pertussis isolate. Infect Immun 72 8 (2004) 4874-4877
25. Garenne M. Sex differences in measles mortality: a world review. Int J Epidemiol 23 3 (1994) 632-642
26. Eupertstrain. http://www.eupertstrain.org/.
27. Khelef N., Danve B., Quentin-Millet M.J., and Guiso N. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun 61 (1993) 486-490
28. Caro V., Hot D., Guigon G., Hubans C., Arrivé M., Soubigou G., et al. Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization. Microbes Infect 8 (2006) 2228-2235
29. Caro V., Elomaa A., Brun D., Mertsola J., He Q., and Guiso N. Bordetella pertussis, Finland and France. Emerg Infect Dis 12 6 (2006) 987-989
30. Packard E.R., Parton R., Coote J.G., and Fry N.K. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J Med Microbiol 53 Pt 5 (2004) 355-365
31. Pertussis surveillance in Sweden. http://www.smittskyddsinstitutet.se/SMItemplates/Article_5894.aspx.
32. King A.J., Berbers G., van Oirschot H., Hoogerhout P., Knipping K., and Mooi F.R. Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology-Sgm-Microbiology-(UK) 147 Part 11 (2001) 2885-2895
33. Gzyl A., Augustynowicz E., Gniadek G., Rabczenko D., Dulny G., and Slusarczyk J. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates. Vaccine 22 17-18 (2004) 2122-2128
34. Boursaux-Eude C., Thiberge G., Carletti G., and Guiso N. Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine. Vaccine 17 (1999) 2651-2660
35. Denoel P., Godfroid F., Guiso N., Hallander H., and Poolman J. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model. Vaccine 26 (2005) 26